Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Yoshihiko Aizawa"'
Autor:
Yoshihiko Aizawa, Katsumi Yoshida, Noriyo Sayama, Keishi Abe, Hirunobu Hori, Naoki Nakasato, Hiroshi Fukazawa, Yoshinori Kiso, Jun-ichi Tani, Kouki Mori
Publikováno v:
Endocrine Journal. 45:117-121
A 33-year-old woman with signs and symptoms of hypothyroidism, including increased thyroid stimulating blocking antibody (TSBAb) activity, was referred for treatment by her local physician. Her monozygote twin was treated for hyperthyroid Graves' dis
Autor:
Hiroshi Fukazawa, Yoshinori Kiso, Naoki Nakazato, Noriyo Sayama, Keishi Abe, Hironobu Hori, Yoshihiko Aizawa, Katsumi Yoshida, Jun-ichi Tani, Nobuko Kaise
Publikováno v:
Clinical Endocrinology. 48:17-22
OBJECTIVE We recently reported that thyroid-stimulating blocking antibody (TSBAb) may not contribute to the development of hypothyroidism more than six years after 131I treatment. In the present study, we attempted to determine whether hypothyroidism
Autor:
Noriyo Sayama, Nobuko Kaise, Keishi Abe, Yoshihiko Aizawa, Katsumi Yoshida, Hiroshi Fukazawa, Hironobu Hori, Yoshinori Kiso
Publikováno v:
Clinical Endocrinology. 46:1-5
Objective Recovery of thyroid function in patients following hypothyroidism induced by 131I therapy for Graves' disease has been described, but only a few detailed clinical and biochemical studies of this phenomenon (transient hypothyroidism) have be
Autor:
Kouki Mori, Keishi Abe, Yoshinori Kiso, Hiroshi Fukazawa, Noriyo Sayama, Yoshihiko Aizawa, Hironobu Hori, Kyou Kikuchi, Yoshida K, K Endo
Publikováno v:
Endocrinology. 137:1828-1832
Individuals with hyperthyroidism exhibit red blood cell concentrations of carbonic anhydrase I (CAI) that reflect the integrated serum thyroid hormone concentration over the preceding few months. Furthermore, T3, at a physiological free concentration
Autor:
Hiroshi Fukazawa, Yoshinori Kiso, Kouki Mori, Noriyo Sayama, Keishi Abe, Yoshihiko Aizawa, Kyou Kikuchi, Katsumi Yoshida
Publikováno v:
Endocrine Journal. 42:753-760
The kinetics of type III iodothyronine deiodinase (5-D) in rat placenta and brain and the role of phospholipids in enzyme activity were determined. Pregnant Sprague-Dawley rats were given either vehicle (control group) or T4 (15 micrograms/100 g bw/d
Autor:
Keishi Abe, Kazuyasu Endo, Hiroshi Fukazawa, Kouki Mori, Kyou Kikuchi, Katsumi Yoshida, Yoshihiko Aizawa
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 79:71-75
We recently have reported that patients with hyperthyroidism have red blood cell carbonic anhydrase I (CAI) levels that reflect the patient's integrated thyroid hormone level over the preceding few months. In the present study, the effect of T3 on CA
Autor:
Kouki Mori, Yoshihiko Aizawa, Kyou Kikuchi, Keishi Abe, Nobuko Kaise, Takamasa Kayama, Yoshinori Kiso, Katsumi Yoshida, Hiroshi Fukazawa
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 77:1198-1202
To determine whether human brains contain deiodinating pathways, we studied the activity of T4 5-monodeiodinase (5-D) in 20 human brain tumors obtained intraoperatively, including astrocytoma (10), meningioma (4), oligodendroglioma (2), glioblastoma
Autor:
Kouki Mori, Noriyo Sayama, Yoshinori Kiso, Hiroshi Fukazawa, Keishi Abe, Yoshida K, Hironobu Hori, Nobuko Kaise, Yoshihiko Aizawa
Publikováno v:
Journal of endocrinological investigation. 19(10)
Thyroid-stimulating antibody (TSAb) activity and the TSH-binding inhibitory immunoglobulin (TBII) index were assessed in 158 patients with Graves' disease who had been treated with 131I 6-14 years earlier. Twenty-one patients (13%) were still hyperth
Autor:
Katsumi Yoshida, Noriyo Sayama, Hiroshi Fukazawa, Akira Rikimaru, Kohki Mori, Yoshihiko Aizawa, Kyou Kikuchi, Nobuko Raise, Yoshinori Kiso, Keishi Abe
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 5(5)
Intercellular adhesion molecule (ICAM-1), a ligand for lymphocyte function-associated antigen-1 (LFA-1), plays an important role in a variety of immune-mediated mechanisms such as lymphocyte attachment to cultured Graves' thyroid cells. We report the
Autor:
Keishi Abe, Noriyo Sayama, Yoshida K, Kazuro Kaise, Kyou Kikuchi, Yoshinori Kiso, Nobuko Kaise, Kouki Mori, Yoshihiko Aizawa, Hiroshi Fukazawa
Publikováno v:
Clinical endocrinology. 42(5)
Summary OBJECTIVE Graves' disease is recognized as an organ-specific autoimmune disorder caused by the presence of TSH receptor antibodies. The long-term effects of 131I treatment for Graves' disease on TSH receptor antibodies have not previously bee